General AML

Ellen Ritchie | ASH 2018 | Clinical trial accrual in US

L:

Ellen Ritchie from Weill Cornell Medicine, New York, US, talks about a study presented by Uma Borate at the 2018 American Society of Hematology meeting. In this study, a systematic review of therapeutic clinical trials focusing on adult FLT3+ acute myeloid leukemia (AML) was analyzed. 

Download this article:

You can now download this article in Adobe PDF® format.

Download as PDF
Was this article informative? Thank you for your feedback!